Tech Center 1700 • Art Units: 1600 1621 1622 1626 1759
This examiner grants 69% of resolved cases
Valerie Rodriguez-Garcia is an examiner in Tech Center 1700, Art Unit 1600. She has handled 832 resolved cases, maintaining an allowance rate of 68.9 percent. This rate provides a positive outlook for applicants, suggesting that a majority of the applications reaching a resolution are granted. Practitioners can use this 68.9 percent figure to set realistic expectations for the outcome of their patent filings in this tech center.
The interview lift for this examiner is 31.8 percent. This is a significant lift, indicating that interviews are very effective at moving cases toward allowance. The 31.8 percent increase suggests that direct engagement with the examiner is an impactful step a practitioner can take. Given the 832 resolved cases, this lift is a statistically reliable indicator that interviews should be considered a key part of the prosecution strategy.
The median days to allowance is 901. This timeframe offers a benchmark for the speed of the examination process from filing to grant. For those in Art Unit 1600, the 901 days represent a standard duration for successful prosecution. Managing a docket of 832 cases while maintaining this median timeline provides a clear picture of the examiner's typical workflow and efficiency.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18661776 | SKIN CARE COMPOSITION COMPRISING HYDROXYCINNAMIC ACID AND NIACINAMIDE DERIVATIVE | Non-Final OA | The Procter & Gamble Company |
| 18019501 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII | Non-Final OA | BASF SE |
| 17997872 | FUNGICIDAL COMPOSITIONS | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18272221 | GLYCIDYL (METH)ACRYLATE COMPOSITION | Final Rejection | MITSUBISHI GAS CHEMICAL COMPANY, INC. |
| 16807102 | METHODS FOR TREATING PROTEINOPATHIES | Non-Final OA | Genzyme Corporation |
| 18579733 | AAK1 INHIBITOR AND USE THEREOF | Non-Final OA | Xizang Haisco Pharmaceutical Co., Ltd. |
| 17771732 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Non-Final OA | Elanco Animal Health GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy